Artenimol

drugbox
IUPAC_name = (3"R",5a"S",6"R",8a"S",9"R",10"S",12"R",12a"R")-Decahydro-3,6,9-trimethyl-3,12-epoxy-12"H"-pyrano(4,3,-j)-1,2-benzodioxepin-10-ol


CAS_number = 81496-81-3
ATC_prefix = P01
ATC_suffix = BE05
PubChem = 179336
DrugBank =
C=15|H=24|O=5
molecular_weight = 284.348 g/mol
bioavailability =
protein_bound =
metabolism =
elimination_half-life =
excretion =
pregnancy_AU =
pregnancy_US =
pregnancy_category=
legal_AU =
legal_CA =
legal_UK =
legal_US =
legal_status =
routes_of_administration =

Artenimol is an antimalarial drug. It is a semi-synthetic derivative of artemisinin. Its primary use is as an intermediate in the preparation of experimental artemisinin-derived antimalarial drugs. [cite journal | author = Soon Hyung Woo, Michael H. Parker, Poonsakdi Ploypradith, John Northrop and Gary H. Posner |title= Direct conversion of pyranose anomeric OH→F→R in the artemisinin family of antimalarial trioxanes |journal = Tetrahedron Letters |volume =39 |issue= 12 |year=1998| pages= 1533-1536| doi=doi:10.1016/S0040-4039(98)00132-4 |url= http://www.sciencedirect.com/science?_ob=ArticleURL&_udi=B6THS-3SHKHRD-P&_user=10&_rdoc=1&_fmt=&_orig=search&_sort=d&view=c&_acct=C000050221&_version=1&_urlVersion=0&_userid=10&md5=30b29298d7f7d7c8f81b87e3491376ae]

References